Is Netflix a Must-own Stock?
The early months of 2025 have been very hard on…
Sell
44
GPCR Quote, Financials, Valuation and Earnings
Last price:
$23.77
Seasonality move
:
18.95%
Day range:
$23.20 - $24.19
52-week range:
$13.22 - $62.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.57x
Volume:
728.6K
Avg. volume:
1.1M
1-year change:
-35.08%
Market cap:
$1.4B
Revenue:
--
EPS (TTM):
-$2.35
Earnings Data
Next earnings date for GPCR
May 09
2025
Most recent earnings per share
-$0.64
Missed by $0.47
(Feb 27/2025)
Consensus Estimate
-$0.17
(Feb 27/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GPCR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.24 | -- |
| 05/09/2025 | Q1 | -- | -- | -- | -$0.23 | -- |
| 02/27/2025 | Q4 | -- | -- | -$0.64 | -$0.17 | -$0.47 |
| 11/13/2024 | Q3 | -- | -- | -$0.60 | -$0.19 | -$0.41 |
| 08/08/2024 | Q2 | -- | -- | -$0.54 | -$0.23 | -$0.32 |
| 05/09/2024 | Q1 | -- | -- | -$0.57 | -$0.22 | -$0.35 |
| 03/08/2024 | Q4 | -- | -- | -$0.48 | -$0.21 | -$0.27 |
| 11/17/2023 | Q3 | -- | -- | -$0.63 | -$0.22 | -$0.41 |
| 08/10/2023 | Q2 | -- | -- | -$0.60 | -$0.27 | -$0.33 |
| 05/11/2023 | Q1 | -- | -- | -$0.75 | -$0.37 | -$0.38 |
| 12/31/2022 | Q4 | -- | -- | -$0.31 | -$0.54 | $0.23 |
| 09/30/2022 | Q3 | -- | -- | -$0.49 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.61 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.51 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.61 | -- | -- |
Structure Therapeutics Earnings Questions
-
How Much did Structure Therapeutics Generate in Revenue Last Quarter?
Structure Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Structure Therapeutics Beat Earnings Last Quarter?
Structure Therapeutics announced earnings per share of -$0.64 which represents a miss of analyst forecast a -$0.17 per share.
-
Is Structure Therapeutics Profitable?
Structure Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Structure Therapeutics EPS Next Year?
Structure Therapeutics's earnings are forecast to decrease from -$2.34 per share to -$0.76 per share next year representing a decrease of -70.86%.
-
When is Structure Therapeutics's Earnings Date?
Structure Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Bill Ackman Buy Uber Stock?
In February, Pershing Square manager Bill Ackman revealed that his…
Should You Buy Alibaba Stock Despite the Risks?
Markets rebounded slightly after U.S. President Donald Trump announced a…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 36x
Alerts
Sell
48
FI alert for Apr 25
Fiserv [FI] is up 0.33% over the past day.
Buy
66
FARO alert for Apr 25
Faro Technologies [FARO] is up 0.93% over the past day.
Buy
55
PI alert for Apr 25
Impinj [PI] is up 2.15% over the past day.
